AR078098A1 - Compuesto que contiene nitrogeno y composicion farmaceutica - Google Patents

Compuesto que contiene nitrogeno y composicion farmaceutica

Info

Publication number
AR078098A1
AR078098A1 ARP100103052A ARP100103052A AR078098A1 AR 078098 A1 AR078098 A1 AR 078098A1 AR P100103052 A ARP100103052 A AR P100103052A AR P100103052 A ARP100103052 A AR P100103052A AR 078098 A1 AR078098 A1 AR 078098A1
Authority
AR
Argentina
Prior art keywords
group
lower alkyl
phenyl
alkylene
optionally substituted
Prior art date
Application number
ARP100103052A
Other languages
English (en)
Inventor
Shinichi Taira
Kuninori Tai
Sunao Nakayama
Kenji Tsujimae
Toshiyuki Onogawa
Motohiro Itotani
Takashi Oshiyama
Yasuhiro Menjo
Tsuyoshi Nagase
Kunio Oshima
Shuuji Matsumura
Hokuto Yamabe
Naohiro Isono
Noriaki Takemura
Masataka Ueda
Yasuo Koga
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of AR078098A1 publication Critical patent/AR078098A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/12—1,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Quinoline Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Reivindicacion 1: Un compuesto de diazepina representado por la formula general (1) o una sal del mismo, caracterizado porque R1, R2, R3, y R4 son cada uno independientemente hidrogeno, alquilo inferior, ciclo alquilo inferior o alcoxi inferior alquilo inferior; R2 y R3 pueden ser ligados para formar alquileno inferior; A1 es alquileno inferior opcionalmente substituido con uno o más substituyentes seleccionados entre el grupo que consiste en hidroxilo y oxo; Y1 e Y2 son cada uno independientemente -N= o -CH=; R5 es un grupo representado por (R6-XA)(R7-XB)-N- en donde: R6 y R7 son cada uno independientemente hidrogeno o un grupo orgánico; R6 y R7 pueden ser ligados para formar un anillo junto con el grupo adyacente -XA-N-XB-; XA y XB son cada uno independientemente un enlace, alquileno, alquenileno, -CO-, -SO2- o -CONH-, en donde cada una de las cadenas de alquileno y alquenileno pueden contener opcionalmente uno o más substituyentes seleccionados entre el grupo que consiste en -S-, -C(=S)-, -SO2-, -CO-, -O-, -NH-, -CONH- y -SO2NH-, y el átomo de hidrogeno (H) unido al átomo de nitrogeno (N) en XA y XB es opcionalmente substituido con un substituyente seleccionado entre el grupo que consiste en alquilo inferior, fenilo alquilo inferior y fenilo. Reivindicacion 8: Un compuesto amino representado por la formula general (R1-XA)(R2-XB)-N-A1-O-R3 o una sal del mismo, caracterizado porque R1 y R2 son cada uno independientemente hidrogeno o un grupo orgánico; XA y XB son cada uno independientemente un enlace, alquileno, alquenileno, -CO-, -SO2- o -CONH-, en donde cada una de las cadenas de alquileno y alquenileno pueden contener opcionalmente uno o más substituyentes seleccionados entre el grupo que consiste en -S-, -C(=S)-, -SO2-, -CO-, -O-, -NH-, -CONH- y -SO2NH-, y el átomo de hidrogeno (H) unido al átomo de nitrogeno (N) en XA y XB es substituido opcionalmente con un substituyente seleccionado entre el grupo que consiste en alquilo inferior, fenilo alquilo inferior y fenilo; A1 es alquileno inferior substituido opcionalmente con uno o más substituyentes seleccionados entre el grupo que consiste en hidroxilo y oxo; R3 es (i) un grupo heterocíclico que es substituido opcionalmente con uno o más substituyentes, o (ii) un grupo arilo substituido con uno o más substituyentes seleccionados entre el grupo que consiste en oxo, alquilo inferior, carboxilo, halo-alquilo inferior, alcanoilo inferior alquilo inferior, fenilo alquilo inferior, ciclo alquilo inferior, alcoxi inferior, halo alcoxi inferior, fenilo alcoxi inferior, fenoxi, ciano, hidroxilo, halogeno, nitro, alquiltio inferior, alcanoilo inferior, alcoxi inferior carbonilo, alquenilo inferior, fenilo, triazolilo, isoxazolilo, imidazolilo, pirrolilo, benzo[d]oxazolilo, benzo[d]tiazolilo y el grupo representado por la formula general -Y-N(R4)(R5) en donde Y es un enlace, alquileno inferior o -CO-; R4 y R5 son cada uno independientemente hidrogeno, alquilo inferior, ciclo alquilo inferior, fenilo o alcanoilo inferior; o R4 y R5 pueden ser ligados para formar un anillo junto con el nitrogeno adyacente, y el anillo puede tener opcionalmente uno o más substituyentes.
ARP100103052A 2009-08-21 2010-08-20 Compuesto que contiene nitrogeno y composicion farmaceutica AR078098A1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US23598109P 2009-08-21 2009-08-21
US23598309P 2009-08-21 2009-08-21
US23597309P 2009-08-21 2009-08-21
US35968610P 2010-06-29 2010-06-29

Publications (1)

Publication Number Publication Date
AR078098A1 true AR078098A1 (es) 2011-10-12

Family

ID=43014533

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP100103052A AR078098A1 (es) 2009-08-21 2010-08-20 Compuesto que contiene nitrogeno y composicion farmaceutica

Country Status (25)

Country Link
US (3) US8822453B2 (es)
EP (3) EP2727917A1 (es)
JP (2) JP5769700B2 (es)
KR (1) KR20120081973A (es)
CN (1) CN102482234B (es)
AR (1) AR078098A1 (es)
AU (2) AU2010285621A1 (es)
CA (1) CA2771579A1 (es)
CO (1) CO6440511A2 (es)
DK (1) DK2467364T3 (es)
ES (1) ES2477221T3 (es)
HK (1) HK1167391A1 (es)
HR (1) HRP20140636T1 (es)
IL (2) IL217101A0 (es)
IN (1) IN2012DN01985A (es)
MX (1) MX2012002149A (es)
NZ (1) NZ598918A (es)
PL (1) PL2467364T3 (es)
PT (1) PT2467364E (es)
RU (1) RU2012110553A (es)
SG (1) SG177316A1 (es)
SI (1) SI2467364T1 (es)
TW (1) TWI481601B (es)
WO (1) WO2011021726A2 (es)
ZA (1) ZA201201025B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2553676C2 (ru) * 2009-08-21 2015-06-20 Оцука Фармасьютикал Ко., Лтд. СПОСОБ ПОЛУЧЕНИЯ ПРОИЗВОДНОГО БЕНЗО[b][1,4]ДИАЗЕПИН-2,4-ДИОНА
WO2012162818A1 (en) * 2011-06-03 2012-12-06 Queen's University At Kingston Substituted diarylamines and use of same as antioxidants
US8940742B2 (en) 2012-04-10 2015-01-27 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
CN102627597B (zh) * 2012-04-25 2013-10-23 山东轻工业学院 吲哚-3-甲醛异丁酰腙类衍生物及其制备方法
US9849127B2 (en) 2013-05-14 2017-12-26 Medizinisch Hochschule Hannover Means and methods for treating cancer
JP6466924B2 (ja) 2013-10-04 2019-02-06 インフィニティー ファーマシューティカルズ， インコーポレイテッド 複素環式化合物及びその使用
US9751888B2 (en) 2013-10-04 2017-09-05 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
DK3119397T3 (da) 2014-03-19 2022-03-28 Infinity Pharmaceuticals Inc Heterocykliske forbindelser til anvendelse i behandling af PI3K-gamma-medierede lidelser
WO2016054491A1 (en) 2014-10-03 2016-04-07 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
KR20180058741A (ko) 2015-09-14 2018-06-01 인피니티 파마슈티칼스, 인코포레이티드 이소퀴놀리논의 고체형, 그의 제조 방법, 이를 포함하는 조성물 및 이를 사용하는 방법
WO2017161116A1 (en) 2016-03-17 2017-09-21 Infinity Pharmaceuticals, Inc. Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors
US10919914B2 (en) 2016-06-08 2021-02-16 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
WO2018112843A1 (en) 2016-12-22 2018-06-28 Merck Sharp & Dohme Corp. Heteroaryl piperidine ether allosteric modulators of the m4 muscarinic acetylcholine receptor

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3133056A (en) * 1961-05-15 1964-05-12 May & Baker Ltd N-phenylpiperazine derivatives of tetrahydrobenzodiazepines
US4001408A (en) 1966-12-14 1977-01-04 Roussel-Uclaf Substituted heterocyclic compounds, processes and composition including those
US3984398A (en) 1966-12-14 1976-10-05 Roussel-Uclaf 1,5-Benzodiazepine-2,4-diones
BE707667A (es) 1966-12-14 1968-06-07
GB1460936A (en) 1974-10-01 1977-01-06 Beecham Group Ltd Benzodiazepines
JPS545981A (en) * 1977-06-10 1979-01-17 Otsuka Pharmaceut Co Ltd Carbostyryl derivatives
NZ187452A (en) 1977-06-10 1980-05-27 Otsuka Pharma Co Ltd N- substituted-aminocarbonylpropoxy-carbostyrils and their preparation
JPS54163825A (en) * 1978-06-15 1979-12-26 Otsuka Pharma Co Ltd Phosphoesterase inhibitor
JPS5579372A (en) * 1978-12-08 1980-06-14 Otsuka Pharmaceut Co Ltd Preparation of carbostyril derivative
JPS56122356A (en) 1980-02-29 1981-09-25 Otsuka Pharmaceut Co Ltd Carbostyril derivative
JPS5780322A (en) * 1980-11-05 1982-05-19 Otsuka Pharmaceut Co Ltd Cardiotonic agent
JPS6010008B2 (ja) * 1982-07-12 1985-03-14 大塚製薬株式会社 血小板凝集抑制剤
JP2753622B2 (ja) * 1988-05-02 1998-05-20 大塚製薬株式会社 カルボスチリル誘導体
DE68920797T2 (de) * 1988-08-10 1995-06-29 Otsuka Pharma Co Ltd Herzmittel.
JPH0296133A (ja) 1988-10-01 1990-04-06 Fuji Photo Film Co Ltd ハロゲン化銀カラー写真感光材料
JPH03148223A (ja) * 1989-11-02 1991-06-25 Otsuka Pharmaceut Co Ltd 血小板凝集抑制剤
BR9200951A (pt) * 1991-03-21 1992-11-17 Hoffmann La Roche Compostos, processo para sua producao,preparacoes farmaceuticas e uso
JPH05194405A (ja) * 1991-08-23 1993-08-03 Otsuka Pharmaceut Co Ltd カルボスチリル誘導体及び血小板凝集抑制剤
CA2093633A1 (en) 1991-08-23 1993-02-24 Seiji Sato Carbostyril derivative and platelets aggregation inhibitory agent
PE27497A1 (es) 1994-04-15 1997-08-07 Glaxo Inc Derivados de 1,5 benzodiazepina
US5691331A (en) * 1995-06-07 1997-11-25 Merck & Co., Inc. N-(2,4-Dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3yl) -3- amides
US5700797A (en) 1995-06-07 1997-12-23 Merck & Co, Inc. N-(2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl)-3-amides
JP2964029B2 (ja) * 1995-10-05 1999-10-18 大塚製薬株式会社 カルボスチリル誘導体
TW338037B (en) 1995-10-05 1998-08-11 Otsuka Pharma Co Ltd Carbostyril derivatives possessing platelet aggregation inhibitory activity, antithrombotic activity, intima thinkening, inhibitory activity and phosphoriesterase inhibitory activity, their preparation and pharmaceutical composition
GB0008179D0 (en) 2000-04-05 2000-05-24 Glaxo Group Ltd Chemical process
WO2001010216A1 (en) 1999-08-09 2001-02-15 Merck & Co., Inc. Antiarrhythmic compounds
US6949542B2 (en) 2002-02-06 2005-09-27 Hoffman-La Roche Inc. Dihydro-benzo[b][1,4]diazepin-2-one derivatives
US7772433B2 (en) 2002-02-28 2010-08-10 University Of Tennessee Research Foundation SARMS and method of use thereof
ES2401079T3 (es) * 2002-12-20 2013-04-16 Amgen Inc. Moduladores del asma y de la inflamación alérgica
AR055203A1 (es) * 2005-08-31 2007-08-08 Otsuka Pharma Co Ltd Derivados de benzotiofeno con propiedades antipsicoticas
JP2007290984A (ja) * 2006-04-21 2007-11-08 Kowa Co コフィリン結合剤、及びコフィリン結合剤を有効成分とする抗癌剤
JP4785881B2 (ja) 2007-02-27 2011-10-05 大塚製薬株式会社 医薬
MX2010009269A (es) * 2008-02-22 2010-09-14 Otsuka Pharma Co Ltd Compuesto de benzodiazepina y composicion farmaceutica.

Also Published As

Publication number Publication date
AU2016210778A1 (en) 2016-08-25
JP5769700B2 (ja) 2015-08-26
AU2010285621A1 (en) 2012-01-12
SI2467364T1 (sl) 2014-06-30
HK1167391A1 (en) 2012-11-30
WO2011021726A3 (en) 2011-06-16
EP2727917A1 (en) 2014-05-07
IL217101A0 (en) 2012-02-29
HRP20140636T1 (hr) 2014-10-10
US8822453B2 (en) 2014-09-02
SG177316A1 (en) 2012-02-28
EP2746272A1 (en) 2014-06-25
CO6440511A2 (es) 2012-05-15
WO2011021726A2 (en) 2011-02-24
EP2467364B1 (en) 2014-04-16
RU2012110553A (ru) 2013-09-27
CN102482234A (zh) 2012-05-30
IN2012DN01985A (es) 2015-07-24
ES2477221T3 (es) 2014-07-16
CN102482234B (zh) 2016-04-13
JP2015199748A (ja) 2015-11-12
CA2771579A1 (en) 2011-02-24
ZA201201025B (en) 2013-05-29
US20140343278A1 (en) 2014-11-20
EP2467364B9 (en) 2015-02-18
US20140343277A1 (en) 2014-11-20
PT2467364E (pt) 2014-07-10
PL2467364T3 (pl) 2014-12-31
US20120225866A1 (en) 2012-09-06
TW201111356A (en) 2011-04-01
DK2467364T3 (da) 2014-06-30
NZ598918A (en) 2014-03-28
JP2013502378A (ja) 2013-01-24
MX2012002149A (es) 2012-03-07
US9212187B2 (en) 2015-12-15
EP2467364A2 (en) 2012-06-27
IL247086A0 (en) 2016-09-29
KR20120081973A (ko) 2012-07-20
TWI481601B (zh) 2015-04-21

Similar Documents

Publication Publication Date Title
AR078098A1 (es) Compuesto que contiene nitrogeno y composicion farmaceutica
PE20140863A1 (es) Compuestos de benceno sustituidos con arilo o heteroarilo
PE20120992A1 (es) Conjugados de dimeros de pirrolo[1,4] benzodiazepina como agentes anticancerosos
CO6321166A2 (es) Compuestos de pirrol
AR111811A2 (es) Compuestos derivados de 1,2,4-oxadiazol y composiciones para el control de nematodos
PE20130647A1 (es) Indoles
ES2600636T3 (es) Spiro-[1,3]-oxazinas y spiro-[1,4]-oxazepinas como inhibidores de BACE1 y/o BACE2
AR087452A1 (es) Composiciones de combustible
AR085615A1 (es) Derivados de fluoropiridinona utiles como agentes antibacterianos y composiciones farmaceuticas que los contienen
UY32547A (es) Piperidinas sustituidas como antagonistas de ccr3
AR080057A1 (es) Piridinas disustituidas como anticancerigenos
UY32606A (es) Sulfonamidas nematocidas
CO6140056A2 (es) Compuestos amino -5-4(difluorometoxi)fenil sustituido-5-fenilimidazolona como inhibidores de beta -secretasa
AR074435A1 (es) Derivados de 1,3-benzotiazol, medicamentos que los contienen y uso de los mismos en el tratamiento del cancer.
AR070558A1 (es) Derivados de 7-fenil-7h-pirrolo-[2,3d]-pirimidin-2-il-amino,proceso para prepararlos, composiciones farmaceuticas que los comprenden y uso de los mismos para el tratamiento de enfermedades dependientes de tirosinquinasas,tales como enfermedades proliferativas.
CO6321232A2 (es) Compuesto de tropano como inhibidores de hsp90
PE20091343A1 (es) Compuestos derivados de heterociclo biciclicos como moduladores de gpr119
CR9459A (es) Derivados benzodioxano y benzodioxolano y usos de los mismos
PA8809001A1 (es) Compuestos organicos
DOP2011000281A (es) Derivados de benzofurano
AR077977A1 (es) Compuestos y composiciones como inhibidores de cinasa de proteina
ES2630079T3 (es) Moduladores de la ruta del complemento y usos de los mismos
CO6190626A2 (es) Compuestos y composiciones como inhibidores de proteasa activadora de canal
AR065583A1 (es) Compuestos macrociclicos y composicion farmaceutica
PE20141940A1 (es) Compuestos triciclicos, composiciones que los comprenden y usos de los mismos

Legal Events

Date Code Title Description
FB Suspension of granting procedure